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INTRODUCTION 1 
During recent times, many efforts have been extended to investigate 
the metabolism of selenium compounds-in microorganisms, animals and 
plants. Several investigators (1-3) have proposed some hypothetical 
metabolic pathways for selenium. However, the role of selenium in the 
life ftmction of animals remains unknown. 
Liver necrosis, as induced by the feeding of a Torula yeast diet 
which is unsupplemented with vitamin E and selenium, is known to be a 
fatal symptom in rats (4-6). The addition of either vitamin E or 
selenium to the diet is associated with the prevention of this 
condition. Schwarz (7) has suggested that vitamin E and selenium play 
their effect on the same syndrome by acting on alternate pathways of 
one stage in energy metabolism, thus enabling either substance to 
promote the over-all reaction. Tappel (8) has proposed that either 
substance acts to stabilize unsaturated lipids in the intact animal, 
i. e. , as antioxidant in preventing lipid peroxidation and accompanying 
cellular damage. The report that the necrogenic syndrome may occur 
when rats are fed a diet low in polyunsaturated fat (9) does not 
appear to support the explanation offered by Tappel. 
Little information is available about the effect of vitamin E on 
selenium metabolism in animals. In an experiment with rats, Hopkin� 2 
1 The writing style of the Journal of Nutrition is adopted as a 
guide in preparing this thesis. 
2 Hopkins, L. 1962 Ph. D. Thesis, University of Wisconsin. 
1 
2 
observed that vitamin E-deficient and vitamin E-supplemented animals 
which were given a small dose of selenium-75 both showed similar accu­
mulation of selenium in the tissues and excretion in the urine. In a 
chick study, Jensen et al. (10) found that supplementing a Torula yeast 
basal diet containing 1 ppm of selenium with 20 IU of vitamin E per 
gram did not change the pattern of selenium retention in the tissues. 
While these results indicated a negative relationship between selenium 
metabolism and the presence of vitamin E in· the diet, it is recognized 
that the measurements were not concerned with especial selenium 
metabolites. 
At the present time, the important reactions of selenium in the 
animal are not understood. Various selenium substances have been 
detected in small amounts in biological systems, but these substances 
are analogues of important sulfur metabolites so it has not been possi­
ble to conclude that they have individual functions. These substances 
include selenomethionine (11-13), selenocysteine (13-15), selenocystine 
(11, 16), selenotaurine (17), Se-methylselenocysteine (18), seleno­
coenzyme A (19), selenocystathionine (16, 20), adenosine phosphoselenate 
(21,22) and Se-adenosylselenomethionine (23, 24). However, some infor­
mation about the end products of selenium metabolism is now evident. 
McConnell and Portman (25) have demonstrated that dimethylselenide 
occurs in the breath of rats injected with a high dose of selenate-Se. 
Palmer et al. (26) have observed that the trimethylselenonium ion 3 
3 Hereafter referred to as TMSe moiety or TMSeCl. 
3 
(TMSe) is a major metabolite of selenium in the urine of rats injected 
with varied levels of selenite or else fed a selenite-supplemented 
diet. Byard and Baumann4 have made somewhat similar observations. 
Palmer5 h�s further observed that other compounds of selenium, i. e. , 
selenate and selenomethionine, are sources of the urinary TMSe ion and 
that other animals (turkeys) also excrete it. Thus, it is now possible 
to conclude that methylated selenium is a major end product of 
selenium metabolism. However, information about whether a form such 
as the TMSe ion has biological activity is not established . It may be 
significant that recent work by Obermeyer6 indicates that TMSeCl is 
· relatively non-toxic to the rat, i.e. , a detoxified form of selenium. 
In the experiments of the author, the biological activity of TMSeCl 
was tested and compared with the known activity of sodium selenite and 
of vitamin E with regard to the prevention of liver necrosis and death 
in the rat. The in vivo metabolic reactivity of TMSe ion was also 
studied by injecting Se7 5-labeled TMSeCl into rats fed necrogenic 
(necrosis producing) and non-ne�rogenic diets and then observing the 
form(s) of selenium in the urine by means of paper chromatographic and 
autoradiographic techniques. The effect of the necrogenic syndrome on 
selenite-Se75 metabolism by the rat was also investigated by similar 
methods. 
4 Byard, J. L .  and C. A. Baumann 1968 Fed. Proc·., 27:417 (abstr. 
1146) . 
5 Palmer, I. S .  In preparation. South Dakota State University 
6 Obermeyer, B. D. 1969 M. S . . Thesis, South Dakota S tate University. 
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EXPERIMENTAL 
Biological Activity of Dietary Trimethylselenonium-Se 
Male albino rats7 weighing approximately 40-50 g at 3 weeks of age 
were used. All animals were fed a Torula yeast basal diet (table 1) 
for 1 week to partially deplete them of selenium and vitamin E 
reserve$. They were then allotted at random into the control group 
(basal diet) and treatment groups which were fed the basal diet plus 
each of the following 6 different supplements: 0. 15 and 1. 50 ppm of 
chemosynthetic8 TMSeCl-Se, 0. 15 and 1. 5 ppm of biosynthetic8 TMSeCl-Se, 
0. 15 ppm sodium selenite-Se and 120 ppm vitamin E. The diet and water 
(deionized) were allowed ad libitum in this experiment as well as in 
other experiments. 
The extent of survival and of liver necrosis of the animals fed the 
TMSeCl diets was compared with that of the animals fed either the 
selenite- or vitamin E-supplemented (protective) diet (7) .  
Non-survival was marked by an acute illness at 3-4 weeks from the 
beginning of the feeding of the Torula yeast diet. The rats were 
generally sacrificed at the acute stage, the livers being removed and 
examined visually for necrotic areas (27) . After one month from the 
7 Albino rats used in this and other experiments were purchased 
from Sprague-Dawley, Inc. , Madison, Wisconsin 53711_-
8 Both chemosynthetic and biosynthetic TMSeCl were prepared 
according to Palmer et al. (26) . 
TABLE 1 
Composition of Torula yeast basal diet 1 
Torula yeast 
Sucrose 
Lard, vitamin E-free 
Salt mixture2 
Vitamin mixture, vitamin E-free3 
30. 0 
58. 8 
5. 0 
4. 0 
2. 2 
1 All ingredients are supplied by Nutritional Biochem­
icals Corporation, Cleveland, Ohio. 
2 Salt mixture as described by Bernhart and Tomarelli 
(28). 
3 Vitamin diet fortification mixture in dextrose. The 
vitamin mixture supplied t�e following per 100 g of diet: 
vitamin A, 1980 IU; vitamin D, 220 IU; and (in mg) ascoroic 
acid, 99; inositol, 11; choline chloride, 165; menadione, 
4. 95; p-aminobenzoic acid, 11; niacin, 9. 9; riboflavin, 2. 2; 
pyridoxine•HCl, 2. 2; thiamine•HCl, 2.2; Ca pantothenate, 
6. 6; and (in µg) biotin, 44; folic acid, 198; vitamin B 12, 
2. 97. 
5 
start of this experiment, the remaining rats were also sacrificed to 
facilitate examination of their livers. 
Metabolic Reactivity of Injected Trimethylselenonium-Se 
Male albino rats of 40-50 g initial weight were fed the basal diet 
(table 1) for 7 days. They were then allotted at random into two 
groups,. one being continued on the basal diet and the other being fed 
the basal diet plus 120 ppm of vitamin E. At the time when lethal 
symptoms became evident with the animals fed the basal diet (see 
previous experimental section), the animals of both treatments were 
each injected intraperitoneally with Se75-labeled9 TMSeCl supplying 
12 µg of s_elenium and 4. 2 µC of radioactivity per 100 g of body weight 
of an animal. This dose was in 0.25 ml of solution. The animals of 
both treatments were fasted 12 hours before the injection and 6 hours 
afterward. Immediately on injection the animals were placed individ­
ually in stainless steel metabolism cages which allowed collection of 
6 
9 TMSeCl-Se75 was prepared according to Palmer et al. (26) with a 
slight modification. Urine was collected from rats injected with a 
high dose of sodium selenite-Se75 • Radioactive TMSe-reineckate was 
obtained directly from the urine (29). This TMSe-reineckate salt was 
then converted to TMSeCl-Se 7 5 by using a AG2-X8 resin (200-400 mesh,. 
chloride form). Finally TMSeCl-Se7 5  was repeatedly purified by using 
paper chromatography along with autoradiography. This pure TMSeCl-Se75 
was mixed with carrier chemosynthetic TMSeCl to give the injection 
solution, each ml containing 48 µg of selenium (sp. act. 0.35 µC/µg). 
7 
the urine • . The mean body weights of the animals fed the basal diet and 
the basal diet plus vitamin E were 101 and 109 g, _ respectively, at this 
time. The urine was collected at room temperature in 12 ml centrifuge 
tubes. The collection periods covered intervals of 0-12, 13-24 and 
25-144 hours. The urine samples were centrifuged in a Sorvall RC-2 
automatic refrigerated centrifuge. The volume of supernatant was 
measured. The supernatant was stored in a freezer prior to measurement 
of the total·se75 activity and the-separate activity of entities on 
the chromatogram. 
The total Se75 activity was measured on all samples of urine. A 
·50 µ1 portion of each was counted with a Packard well-type auto-gamma 
spectrometer. A given portion of the injection dose of TMSeCl-Se7S 
was similarly counted and then the per cent of the dose represented in 
each sample was calculated. 
The separate activity of chromatographic entities was studied as 
follows: �O µl portions of each first 12-hour sample were applied to 
duplicate sheets of Whatman No. 1 chromatographic paper (46 x 57 cm) . 
Each paper was then developed in the first dimensional solvent 
(phenol:water, 73:27, w/w) for approximately 16 hours with a traveling 
distance of 40  cm. After being dried in a 70 °c oven, the chromatogram 
was further developed in the second dimensional solvent (butan-1-ol: 
acetic acid:water, 4 :1:1, by vol. ) for 10 hours with an approximate 
30 cm traveling distance. The chromatogram was then placed underneath 
a Kodak no-screen medical X-ray film (35.6 x 43. 2'cm) for sufficient 
time to allow appropriate exposure. Any discrete major spots from Se75 
activity were located on the film following development. These areas 
\ 
8 
were outlined exactly on the chromatogram to facilitate their removal 
and the measurement of their · Se75 activities by the gamma counting 
methods. ·The position of the primary spot, designated as U-1, was at 
the same time used as the reference (R0_1 = 1) in calculating the R0_1 
values of other major spots, if present. To facilitate the counting 
of other areas of the paper in a reproducible manner, the paper was 
sectioned at lines corresponding to R0_1 values of 0. 2, 0. 4, 0. 6, 0. 8, 
1. 0 and 1. 1 along the first solvent movement and at values of 0. 5, 1. 0, 
1. 5, 2. 0 and 2. 4 along the second movement. The divided parts of the 
.chromatogram were also counted for Se75 activity. Their activities 
along with those of the separate major spots were calculated in terms 
of percentage of the activity in the urine samples. 
Influence of Vitamin E � Trimethylselenonium Formation 
The procedures used in this experiment were similar to those of 
the preceding section except as described below. A connnercial 
H2Se7503 solution 10 was adjusted to pH 6 with sodium hydroxide and then 
carrier Na2Se0311 was added in order to give 10 µg of selenium and 
80 µC of radioactivity per 0. 2 ml of final solution, this voluine being 
lO This was a highly radioactive selenium-75 as H2Se 7503 in 0. 5 N 
HCl (508 rnC/rng Se). It was purchased from the Nuclear Science Division, 
International Chemical and Nuclear Corp. , Pittsburgh, Pa. 15236. 11 Sodium selenite was prepared as described by Trelease and Beath 
(30) and was pure as determined by Olson et al. (31). 
9 
injected per 100 g of animal weight. Thus, labeled sodium selenite-Se75 
was injected instead of labeled TMSeCl-Se75 in this instance. 
10 
RESULTS 
Biological Activity of Dietary Trimethylselenonium-Se 
The data regarding the effect of dietary TMSeCl-Se supplements on 
the necrogenic syndrome of rats are shown in table 2. In two trials 
where dietary selenite-Se (0. 15 ppm) or vitamin E (120 ppm) protected 
completely against mortality and liver necrosis during a 30-day 
experimental period, chemosynthetic TMSeCl-Se at levels of 0. 15 and 
1. 50 ppm gave no definite protection. Likewise, these levels of 
biosynthetic TMSeCl-Se gave no protection in one trial. The similarity 
of the· time-death relationship between animals fed the basal diet and 
the basal diet plus supplemented TMSeCl (fig. 1) was further evidence 
that TMSe was inactive against the necrogenic syndrome. It was of 
interest that whenever an animal survived the 30-day period when given 
the basal diet or the basal diet plus TMSeCl supplement, the liver 
showed mild necrosis although the animal had always appeared healthy 
during the experiment. 
The appearance of typical non-necrogenic and necrogenic livers is 
shown in figure 2. A liver showing no necrosis, as was the case with 
animals fed sodium selenite-Se or vitamin E, is illustrated in 
photograph A. Livers showing necrosis, as was the case with animals 
fed the basal diet and the basal diet plus TMSeCl-Se, are illustrated 
in photographs B and C, respectively. 
TABLE 2 
Effect of TMSeCl-Se in preventing.mortality and liver necrosis 
with rats fed a Torula yeast diet 
Supplement 
None 
Chemosyn. TMSeCl-Se 
Chemosyn. TMSeCl-Se 
Biosyn. TMSeCl-Se 
Biosyn. TMSeCl-Se 
Sodium selenite-Se 
Vitamin E 
Level 
ppm 
0. 15 
1. 50 
0. 15 
1. 50 
0. 15 
120 
Exp. no. 
1 
2-
1 
2 
1 
2 
2 
2 
1 
2 
1 
2 
% Mortality 1 Liver necrosis 
86 
100 
86 
100 
86 
86 
86 
100 
0 
0 
0 
0 
+2 
+ 
+2 
+ 
+2 
+2 
+2 
+ 
1 Seven rats used for each group of both experiments with 30-day 
period. 
2 The last surviving rat was killed on terminal date. Its.liver 
also showed slight necrosis. Sign (+) indicates necrotic syndrome 
while sign (-) indicates negative result. 
11 
7 
6 
1 
Supplement: 
•�• None 
�-• Chemosyn. TMSeCl-Se, 0. 15 ppm 
A - _
i:,. .Chemosyn. TMSeCl-Se, 1. 50 ppm 
■- • Biosyn. TMSeCl-Se, 0. 15 ppm 
0'- 0 Biosyn. TMSeCl-Se, 1. 50 ppm 
�., .. 
12 
............ _ ... __________ .__. __ 1.._ .... _...i, .... _._�,1...-
0 7 20 22 24 26 28 30 
Days 
Fig. 1. Time-death relationship with rats fed the Torula yeast 
basal diet and the basal diet plus TMSeCl supplements. All rats were 
fed the basal diet for 7 days. They were then grouped and fed the 
respective treatment diets. 
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A 
B C 
Fig. 2. Normal liver (A) in contrast to necrotic'livers (B, C). 
A. Basal diet plus 120 ppm vitamin E or 0. 15 ppm Se as sodium selenite. 
B. Torula yeast basal diet. C. Basal diet plus 0. 15 or 1. 50 ppm.Se 
as trimethylselenonium chloride. 
233083 SOUTH DAKOTA STATE U IVE SITY LIBRARY 
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M etabolic Reactivity of Injected Trimethylselenonium-Se 
The extent to which Se75 activity from injected TMSeCl-Se75 appeared 
in the urine of rats fed either the basal diet (necrogenic) or the 
basal diet plus vitamin E (non-necrogenic) is shown in table 3. About 
70% of the activity of the dose was excreted in the urine during the 
first 12-hour period irrespective of which diet was fed. A smaller 
activity was excreted later so that the total amount excreted over 144 
hours amonnted to about 82%. It was noteworthy that some animals 
excreted almost all of the dose over the 144-hour period with two 
animals.excreting 95% of the total dose in that time. Thus, the 
injected TMSe-Se75 was poorly retained when administered at rather low 
levels to animals, some of which were known to be deficient in factors 
protecting against the necrogenic syndrome, i. e. , selenium or vitamin E. 
The finding that the injected TMSe-Se75 appeared in only one 
substance in the first 12-hour urine is shown on a typical autoradio­
gram with a rat fed the basal diet (fig. 3). Similar results were 
obtained with animals fed the basal diet plus vitamin E. The single 
spot was designated as U-1 (26). On counting the Se 75 activity of this 
area on the chromatogram, it was determined that the single spot 
accounted for all of the activity of the urine (table 4). 
Along with the observance that urine of TMSe 75Cl-injected animals 
gave a single spot of radioactivity on the chromatogram in the area of 
TMSe (26), a further chromatography was used to characterize the 
identity of the spot. In the procedure, a 50 µl·portion of urine 
containing the radioactive U-1 metabolite was mixed with 10 µl of the 
TABLE 3 
Urinary excretion of radioactivity of injected TMSeCl-Se75 with 
rats fed a Torula yeast diet unsupplemented and 
supplemented with vitamin E 
Collection % of TMSeCl-Se75 dose1 excreted 
interval S upplement Exp. 12 Exp. 23 Avg. 4 
hours 
None 77. 13 ±- 2. 81 64 . 30 ± 5. 98  70 . 13 ± 4 . 54 
0----12 
Vitamin E 73. 20 ± 9 . 73 68 . 33 ± 1. 53 70 . 54 ± 5. 26 
None 5. 29 ± 0 . 76 3. 95 ± 0 . 92 4 . 56 ± 0 . 85 
13----24 
Vitamin E 5. 04 0 . 50 4 . 44 0 . 64 4 . 71 0 . 58 ± ± ± 
None 4 . 87 ± 1. 38 9 . 81 ± 3. 4 6  7. 0 6  ± 2. 31 
25---144 
8 . 12 3. 61  5. 28 0 . 63 6 . 57 1. 9 9  Vitamin E ± ± ± 
None 87. 09 ± 3. 01 74 . 49 ± 4 . 56 81. 4 9  ± 3. 70 
Total, 0-144 
Vitamin E 86 . 36 ± 5. 92 78 . 04 ± 1. 47 81. 83 ± 3. 49  
1 Injection dose for rat per 100 g body weight: Exp. 1, 4 .  2 µ C 
Se75 as H2Se03 and 12 µg Se as Na2 Se03; Exp. 2, 10 µC and 10 µg Se, 
respectively. 
2 Mean ± SE of 5 rats. 
3 Mean ± SE of 6 rats. 
4 Weighed Mean ± SE of Exp. 1 and 2. 
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PHENOL-WATER (73 27w/w) 
Fig. 3. Typical autoradiogram of two-dimensional chromatogram from 
urine sample of rats fed a Torula yeast basal diet or the basal diet 
plus vitamin E. Rats were injected with Se75-labeled TMSeCl. Fifty 
microliters of the first 12-hour urine were applied·to the origin. The 
designated U-1 was the only radioactive selenium metabolite in the 
urine and it was confirmed as TMSe. The phenol solvent was used first. 
TABLE 4 
Occurrence of urinary radioactivity as U-1 with rats 
injected with Se75-labeled TMSeC1 1 
Diet 
Basal 
Basal + vitamin E 
% activity of Se75 as u-12 
Exp. 1 3 Exp. 2 4 
100 . 16 ± 1. 58 
99.24 ± 1.14 
100.61 ± 0 . 82 
9 9 . 26 ± 0 . 51 
1 Same animals as described in table 3 data; 0 to 12 hour urine 
samples. 
2 U-1 has a Rf value of 0. 90 and 0.42 along the first and second 
solvent movement, respectively. 
3 Mean ± SE of 5 rats. 
4 Mean ± SE of 6 rats. 
17 
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TMSe75Cl solution (biosynthetic) that was used for injection and with 
10 µg of non-labeled TMSeCl (chemosynthetic). This preparation was 
then subjected to the chromatographic and autoradiographic procedures 
already described. Again, only one discrete spot appeared on the 
autoradiogram. The spot had a Rf value in agreement with that reported 
for TMSe (26). Thus, the activity of the designated U-1 and of the 
TMSe75 were superimposed. When the chromatogram was sprayed with the 
Munier and Macheboeuf modification of Dragendorf's Reagent (32) as 
described by Palmer et al. (26), a single colored spot (pinkish orange) 
which was in the identical position of the spot on the autoradiogram 
was evident. Thus, the movement of the designated U-1, of biosynthetic 
TMSe 75 and of chemosynthetic TMSe on the chromatogram were identical, 
indicating that the injected TMSe occurred unchanged in the urine. 
Influence of Vitamin E on Trimethylselenonium Formation 
When selenite-Se75 was injected into rats fed either the basal diet 
or the basal diet ·plus vitamin E (non-necrogenic), the extent of Se7 5 
activity excreted in the urine was somewhat low (table 5) in comparison 
with the higher and more rapid excretion which was observed when 
TMSeCl-Se 7 S was injected (table 3). In the case of the data shown in 
table 5, the dietary treatment was associated with an effect on the 
se75 activity excreted in the first 12-hour period after the injection. 
This was particularly evident with the animals of experiment 1 where 
those fed the basal diet excreted 13% of the injected activity in the 
interval while those fed the basal diet plus vitamin E excreted 8%. 
19 
TABLE 5 
Urinary excretion of radioactivity of injected Na2seo3-se
75 with 
rats fed a Torula yeast diet unsupplemented and 
supplemented with vitamin E 
Collection % of Na2Se03-se75 dose1 excreted 
interval Supplement Exp. 12 Exp. 23 Avg. 4 
hours 
None 13. 04 ± 1. 30 -9 . 09 ± 1. 65 10 . 88 ± 1. 49 
0----12 
o.1a* Vitamin E 8 . 11 ± 7 . 13 ± 1. 48 7.57 ± 1. 16 
None 9 . 96 ± 0 . 66 3. 66 ± 0.67 6.52 ± 0 . 66 
13----24 
Vitamin E 7 . 9 6 ± 0 . 73 4 . 02 ± 1.01 5.81 ± 0 . 88 
None 11.12 ± 0 . 91a 5. 75 ± 1.27 7 . 90 ± 1. 13 
25---144 
Vitamin E 12. 95  ± 2. 02 5. 49  ± 0.90 8 . 88 ± 1. 41 
None 34 . 93 ± 1. 84a 18 . 50 ± 2.81 25. 07  ± 2. 42 
Total, 0-144 
Vitamin E 29.02 ± 2. 77 16. 64 ± 2. 87 22. 27 ± 2. 82 
1 Injection dose for both experiments: 80 µC Se75 as H2Se03 and 
10 µg Se as Na2Se03 per 100 g rat. 
2 Mean ±  SE of 5 rats, except the value with superscript "a" which 
is Mean ± SE of 4 rats. 
3 Mean ± SE of 6 rats. 
4 Weighed Mean ± SE of Exp. 1 and 2. 
* Indicates significant difference (P < 0 . 05) by t test (33) .  
20 
The Se 75 measurements on later urine collections, i. e. , over 13-24 and 
25-144 hours, did not show significant treatment effects. 
In contrast to the observation that the urine of TMSe 75-injected 
rats contained only the injected form of selenilllll, the first 12-hour 
samples of urine from Na2se
7 So3-injected animals were found to contain 
numerous forms of Se 75 as observed with the chromatographic and 
autoradiographic methods (fig. 4). The most prominent spots on the 
autoradiograms were designated as -u�1, U-2 and U-3, the first spot 
(U-1) corresponding in Rf ·value to TifSe. The respective Rf values for 
U-1, U-2 and U-3 were 0. 90, 0. 86 and 0. 09 along the first solvent 
·movement and were 0. 42, 0. 70 and 0. 04 along the second solvent movement. 
These spots were present whether the animals were fed the basal diet or 
the basal diet plus vitamin E. The presence of vitamin E in the diet 
had an effect on the proportion of urinary Se 75 activity represented by 
U-1 and U-2 but apparently not on the proportion represented by U-3. 
The results shown in table 6 at the bottom of the chromatogram chart 
give the values found in one experiment where the urinary Se 75 as U-1 
was reduced from 28 to 18% and that as U-2 was increased from'l4 to 22% 
when the animals received vitamin E in the diet. However, the change in 
either substance did not result in a change of the total combined 
percentage of urinary Se 75 from both substances, i. e. , remaining about 
40�42%. In terms of the total dose excreted in the first 12 hours, 
rats fed the basal diet excreted 2. 53 and 1. 26% as U-1 and U-2, 
respectively, while rats fed the basal diet plus' vitamin E excreted 
1. 26 and 1. 54%, correspondingly. Thus, the presence of vitamin E in 
Fig. 4 .  Typical autoradiograms of two-dimensional chromatogram 
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from urine sample of rats fed a Torula yeast basal diet (Photograph A, 
page 22) and the basal diet plus vitamin E (Photograph B, page 23). 
Rats were injected with Se75-labeled Na2 Se03• Fifty microliters of the 
first 12-hour urine were applied to the origin. The designated U-1 
(confirmed as TMSe), U-2 and U-3 were major urinary Se7 5  metabolites. 
(Note the similar distribution of minor areas of Se75 activity with 
the two chromatograms). The phenol solvent was used first. 
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TABLE 6 
Percentage of Se7 5  activity on chromatogram of the first 12 hr urine after injecting 
sodium selenite-se75 with rats fed a basal diet (top figures) and a 
2. 4 
0.08 ± 0 . 02 
0 . 06 ± 0 . 02 
2.0 
0.23 ± 0 . 04 
0.36 ± 0.03 
1.5 
0.09 ± 0.03 
0.09 ± 0. 02 
1. 0 
0.10 ± 0.04 
0 . 07 ± 0.01 
0.5 
0.29 ± 0.14 
0.08 ± 0.03 
0 0.2 
basal diet plus vitamin E (bottom figures) 1 , 2 
0 . 05 ± 0 . 01 
0.05 ± 0.02 
0.24 ± 0.05 
0 . 47 ± ,0.09 
0.25 ± 0 . 07 
0.25 ± 0.05 
0.65 ± 0 . 10 
0.52 ± 0.10 
3.11 ± 0 . 25 
2.55 ± 0.26 
0.4 
0 . 06 ± 0.02 0.11 ± 0.03 
0.06 ± 0 . 03 0.06  ± 0.03 
0.07 ± 0 . 14 2. 04 ± 0.42 
1. 49 ± o. 33 4.49 ± 1. 62 
1. 03 ± 0 . 17 3. 19 ± 0.33 
1.29 ± 0 . 30 4.51 ± 0 . 75 
2.23 ± 0 . 25 5. 53 ± 0 . 54 
2. 21 ± 0 . 37 6.60  ± 0 . 57 
5.38 ± 0 . 22 6.41 ± 0.40 
4. 74 ± 0 . 36 6 . 32 ± 0 . 36 
0.6 
3 
Relative Ru-1 
0 . 15 ± 0.06  
0.07 ± 0.03 
1.75±0.47 
1. 64 ± o. 65 
I 
3. 61 ± o. 2-r* 
5. 13 ± 0 . 17 
4. 90  ± 0 . 34 
5. 70 ± 0.37 
3.54 ± 0 . 07 
3.22 ± 0 . 35 
0.8 1.0 
0.09  ± 0.02 
0.02 ± 0.01 
0 . 40 ± 0 . 06 
0.50 ± 0.08 
0.92  ± 0.14 
0.65 ± 0 . 10 
0 . 40 ± 0 . 03 
0.21 ± 0 . 02 
2.79 ± 0.40 
1. 65 ± 0. 24 
1. 1 
N 
� 
TABLE 6 (continued) 
Percentage of Se75 activity in major spots excluded from above chart: 
% 
4 Ru-1 
U-1 spot 
27 . 86 ± 1. 49 
17 . 68 ± 3,37 ** 
1. 00 
1. 00 
u�2 spot 
13. 86 ± 1. 02 
21. 67 ± 1. 75** 
0. 96 ± 0. 01 
1. 67 ± o. 01 
1 Same animals as described in Exp. 2, table 5; 0 to 12 hour urine .samples. 
2 All figures are Mean ± SE of 6 rats. 
3 Relati�e Ru-l values are based on the central location of U-1 spot. 
u�3 spot 
7 . 98 ± 1. 73  
5 .  65  ± 1 .  54 
0. 10 ± 0. 01 
0. 10 ± 0. 00 
4 The top and bottom figures represent relative Ru-1 values in the direction of the first and 
second solvent movements, respectively. 
** . ' Highly significant difference (P < 0. 01) by t test (33) . 
N 
u, 
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the diet was associated with an over-all decrease in the U-1 excretion 
and an over-all increase in the U-2 excretion. The other activity of 
the chromatogram, exclusive of that of U-1, U-2 and U-3, is shown for 
the designated areas of the chart (table 6) . Except for a significant 
difference in one area representing only 4 or 5% of the urinary S� 75 
activity, the dietary treatment did not appear to affect the presence 
of the other selenite-derived selenium compounds of the urine. It was 
of interest to observe that the Se75 activity measured throughout the 
chromatogram accounted for essentially all of the activity which was 
present in the urine, so loss of any of the selenium by volatilization 
· did not appear to be a factor. 
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DISCUSSION 
The recent studies by Byard and Baumann 1 2, Palmer et al. (26) and 
Obermeyer l 3  together with the results of this report enable new 
conclusions about selenite-Se metabolism in the rat. The identifica­
tion of TifSe as a primary form of urinary selenium by Byard and 
Baumann 1 2 and Palmer et al. (26) established the concept that oxidized 
selenium is reduced in metabolism under or�inary conditions since the 
selenium was administered at both low and high levels. Previously, it 
was known that such selenium was reduced when administered at high 
levels since the breath contained volatile selenium as dimethylselenide 
(25). The determination by Obermeyer 1 3 that TMSe is relatively non­
toxic when fed or injected while selenite is known to be highly toxic, 
was suggestive that the reduction-methylation process represents a 
detoxification reaction. Indeed, previous work with dimethylselenide 
has given results indicating that this form is also quite non-toxic 
(34). The reported findings of the author indicate that TMSe-Se 
differs from selenite-Se in that it does not react to form other 
urinary selenium compounds and is not biologically active. The 
previous report that an analogous form of sulfur, i. e. ,  trimethyl­
sulfonium chloride, is not a methyl source in animals (35) is of 
interest. Possibly dimethylselenide is also quite inactive in the· 
animal since it has been reported that dimethylsulfide does not appear· 
to be oxidized (36). 
1 2, 13 See footnotes 4 and 6, respectively. 
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The identification of other forms of urinary selenium in rats 
injected with selenite would appear to be important. This is concluded 
from the observance in the present study (table 6) that animals 
affected with the necrogenic syndrome (without dietary vitamin E or 
selenium) appeared to show an abnormality in selenium metabolism. The 
effect consisted in a change in the ratio of the two most prominent 
urinary selenium substances, i. e. , U-1 (TI1Se) and U-2 (unidentified). 
Thus, U-1 and U-2 represented 28-and 14% of· the urinary selenium with 
animals on the necrogenic diet and 18 and 22% of the urinary selenium 
with animals on the non-necrogenic (vitamin E supplemented) diet, 
respectively. It was noticeable that the animals on the necrogenic 
diet also excreted a greater total selenium (from selenite-Se75 ) in the 
urine than did the animals on the non-necrogenic diet, especially 
during the first collection period after the administration of the 
selenium dose (table 5) .  From these results, it appeared that the rats 
showed an enhanced loss of selenite-derived selenium as TMSe when they 
were deficient in vitamin E under conditions when the necrogenic 
syndrome was imminent. The implications of these observations in the 
light of the knowledge that vitamin E and selenite-Se are each capable 
of preventing the necrogenic syndrome is exciting. Undoubtedly, 
knowledge about the structure of U-2 would be of great help in the 
further elucidation of the important reactions of selenite-Se 
metabolism. 
SUMMARY 
1. A Torula yeast diet was used to study the trimethylselenonium 
ion metabolism in the rat. 
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2. Dietary trimethylselenonium (as chloride salt) at 0 . 15 and 1. 50 
ppm levels of selenium was inactive in preventing liver degeneration 
in rats under conditions when 0 . 15 ppm of sodium selenite-Se or 120 ppm 
of vitamin E was active. 
3. About 7 0% of the Se75 activity was recovered from urine in the 
first 12 hours after injecting rats with Se75-labeled trimethyl­
selenonium chloride. An 82% activity was obtained in .a total 6-day 
period . Only one urinary Se75 metabolite was found and it was con­
firmed as trimethylselenonium ion. Vitamin E had no effect on these 
results. 
4 .  The influence of dietary vitamin E on trimethyl_selenonium ion 
formation in vivo was-investigated by injecting rats with sodium 
selenite-Se75 at a low level. While vitamin E-deficient animals 
showed a higher urinary excretion of selenium during the first 12° hours 
after injection, total excretion in 6 days was the same as those 
animals with vitamin E supplementation. When 120 ppm vitamin E was 
included in the basal diet, the urinary Se75 as trimethylselenonium 
me�abolite was significantly decreased while that of another metabolite, 
U-2, was increased .  The sum of these two major metabolites remained at 
about 41% of the first 12�hour urinary excretion of Se75 irrespective 
of the treatments. 
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